Dr. Abel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dana-Farber Cancer Institute
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3000
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2004 - 2007
Massachusetts General HospitalResidency, Internal Medicine, 2000 - 2003
Columbia University Vagelos College of Physicians and SurgeonsClass of 2000
Certifications & Licensure
MA State Medical License 2003 - 2025- American Board of Internal Medicine Hematology
Clinical Trials
- Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia Start of enrollment: 2008 Jun 01
- Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation Start of enrollment: 2018 Jan 01
- Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS Start of enrollment: 2018 Oct 17
- Join now to see all
Publications & Presentations
PubMed
- The Duffy Null Phenotype - Addressing a Source of Discrimination in Cancer Care.Andrew Hantel, Stephen P Hibbs, Lauren E Merz, Gregory A Abel
The New England Journal of Medicine. 2024-11-28 - Smartphone application for longitudinal home gait speed measurement in older adults with blood cancers: A feasibility and acceptability study.Pei-An Lee, Clark DuMontier, Nicholas Groblewski, Wanting Yu, Junhong Zhou
Journal of Geriatric Oncology. 2024-10-23 - Clinical ethics consultation services: public-facing information on NCI-designated cancer center websites.Erica Koranteng, Colin Cernik, Erin Gallagher, Andrew Hantel, Jonathan Marron
The Oncologist. 2024-10-03
Abstracts/Posters
- Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute LeukemiaGregory A. Abel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Clonal Cytopenias of Undetermined Significance Are Common in Cytopenic Adults Evaluated for MDS in the National MDS StudyGregory A. Abel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Challenges Delivering and Measuring High-Quality Palliative Care for Patients With Hematologic Malignancies60th American Society of Hematology Annual Meeting - 12/1/2018
- Special Symposium on Quality60th American Society of Hematology Annual Meeting - 12/1/2018
- Quality of Life and Psychological Distress in Patients with Acute Myeloid Leukemia (AML)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
For Older Patients with Blood Cancer Taking Multiple Medications, New Tool Links Use of Certain Medications to Risk of FrailtyAugust 11th, 2022- Defining Individual Biosignatures Through Precision Health Symptom Science Helps Nurses Deliver Even Better CareNovember 16th, 2021
Cancer Center Ads Focus on Emotions More Than Facts, Study Finds - US NewsFebruary 17th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
